---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-24-000129"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:18:37.643335+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pacira BioSciences appoints Shawn Cross as CFO effective Oct 21, 2024

## Summary
- Shawn Cross appointed CFO effective Oct 21, 2024; succeeds interim CFO Lauren Riker, who remains SVP of Finance.
- Cross brings >25 years of biopharma experience; former CEO/President/CFO of Applied Molecular Transport.
- Annual base salary $525K; annual bonus target 50% of base; inducement awards of 200K stock options and 75K RSUs.
- Inducement awards vest over four years; option exercise price equals Nov 4, 2024 closing price.

## SEC filing metadata
- accession: 0001396814-24-000129
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/pcrx-20241016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-24-000129
- JSON: https://secwatch.observer/filing/0001396814-24-000129.json
- Plain text: https://secwatch.observer/filing/0001396814-24-000129.txt

## Key facts
- Executive change
  Lauren Riker changed role as Senior Vice President of Finance at Pacira BioSciences, Inc..
  - Action: succeeded
  - Role: Senior Vice President of Finance
  source text: Mr. Cross will succeed Lauren Riker, who had been serving as interim Chief Financial Officer since October 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm
- Executive change
  Shawn M. Cross was appointed as Chief Financial Officer at Pacira BioSciences, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: appointed Shawn M. Cross to serve as the Chief Financial Officer of the Company, effective October 21, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.